Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Iterum Therapeutics plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +2 vs. Q4 2023
- Shares held
- 928.8K
- +542.2K (+140.2%) vs. Q4 2023
- Total value
- $1.43M
- +$668.7K (+87.8%) vs. Q4 2023
- New holders
- 5
- 3 more added
- Sold out
- 3
- 1 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $542 |
| Q1 2026 | 18 | $41.3K |
| Q4 2025 | 20 | $557.9K |
| Q3 2025 | 24 | $904.1K |
| Q2 2025 | 24 | $2.38M |
| Q1 2025 | 20 | $1.38M |
| Q4 2024 | 24 | $2.18M |
| Q3 2024 | 18 | $2.22M |
| Q2 2024 | 15 | $494.7K |
| Q1 2024 | 18 | $1.43M |
| Q4 2023 | 16 | $761.6K |
| Q3 2023 | 15 | $184.0K |
| Q2 2023 | 17 | $393.4K |
| Q1 2023 | 17 | $187.3K |
| Q4 2022 | 23 | $243.7K |
| Q3 2022 | 25 | $575.4K |
| Q2 2022 | 39 | $1.18M |
| Q1 2022 | 41 | $1.80M |
| Q4 2021 | 45 | $2.57M |
| Q3 2021 | 42 | $3.45M |
| Q2 2021 | 45 | $26.0M |
| Q1 2021 | 50 | $11.2M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 434,000 | $668.4K | 0.00% | +434,000 | New |
| Apollon Financial, LLC | 224,750 | $346.1K | 0.12% | +24,750+12.4% | Added |
| Renaissance Technologies LLC | 110,326 | $170.0K | 0.00% | +60,404+121.0% | Added |
| New Leaf Venture Partners, L.L.C. | 97,084 | $149.5K | 0.13% | 00.0% | Unchanged |
| Millennium Management LLC | 28,043 | $43.2K | 0.00% | +28,043 | New |
| Vontobel Holding Ltd. | 15,000 | $23.1K | 0.00% | +15,000 | New |
| UBS Group AG | 12,019 | $18.5K | 0.00% | +7,070+142.9% | Added |
| Morgan Stanley | 5,479 | $8.44K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,285 | $1.98K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 468 | $721 | 0.00% | +468 | New |
| Kelly Financial Services LLC | 120 | $185 | 0.00% | 00.0% | Unchanged |
| Blue Bell Private Wealth Management, LLC | 66 | $102 | 0.00% | +66 | New |
| Ancora Advisors, LLC | 38 | $59 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 13 | $20 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 12 | $18 | 0.00% | 00.0% | Unchanged |
| HM Payson & Co | 3 | $5 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 100 | $0 | 0.00% | −9,900−99.0% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,533−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Cypress Capital Management LLC (WY) | 0 | $0 | 0.00% | −66−100.0% | Sold out |